<\/p>\n
Razburljiva nova \u0161tudija je bila objavljena ta mesec in zajema 110 bonikov s ponavljajo\u010do se multiplo sklerozo, ki so jih spremljali 11 let. Primerjali so dve skupini: prva skupina, ki je prejemala standardno terapijo za MS, ter druga skupina, ki je prejemala zdravljenje z krvotvornimi mati\u010dnimi celicami poleg kemoterapije.<\/p>\n
Evalvacije bolnikov so bile narejene 1 leto in 5 let po za\u010detku spremljanja in terapij. Raziskovalci so ugotovili, da je 34 bolnikov iz skupine s standardno terapijo kazalo znake napredovanja bolezni za razliko od skupine zdravljene z mati\u010dinimi celicami, kjer se je stanje poslab\u0161alo 3 bolnikom. V prvem letu se je povpre\u010dni EDSS kazalnik (raz\u0161irjena lestvica statusa invalidnosti) izbolj\u0161al pri skupini zdravljeni z mati\u010dnimi celicami, medtem ko se je pri skupini s klasi\u010dnim zdravljenjem poslab\u0161al.<\/p>\n
28 letna Amanda Loy je bila del skupine, ki je prejela zdravljenje z mati\u010dnimi celicami:<\/p>\n
Sli\u0161i se dramati\u010dno, ampak zdravljenje mi je dejansko vrnilo \u017eivljenje\u2026 nisem pri\u010dakovala vsa ta izbolj\u0161anja. V \u0161tudijo sem \u0161la z namenom, da bom zadovoljna \u017ee, \u010de se stanje ne poslab\u0161a. Vsa izbolj\u0161anja so bila popolnoma nepri\u010dakovana za mene, ampak \u010dudovito presene\u010de.<\/p><\/blockquote>\n
Pred zdravljenjem je bila Amanda zelo prizadeta zaradi MS. Ni bila sposobna delati poln delovnik, imela je te\u017eave z mehurjem in hodila je s pomo\u010djo palice. \u017de prvo leto po za\u010detku zdravljenja z njenimi lastnimi mati\u010dnimi celicami je opazila neverjetne izbolj\u0161ave. Te\u017eave z mehurjem so izginile, prav tako utrujenost, odrevenelost v udih, kot tudi intoleranca na vro\u010dino in bole\u010dine.<\/p>\n
V 11 letih \u0161tudije se je stanje Amandi izbolj\u0161alo do te mere, da lahko dela poln delovni \u010das kot u\u010diteljica. Ukvarja se tudi s \u0161portom in ne potrebuje zdravil za MS.<\/p>\n
To je najbolj\u0161i dokaz, ko primerjamo zdravljenje z mati\u010dnimi celicami z klasi\u010dnim zdravljenjem\u2026To je eden od prvih dokazov, da bolniki z agresivnim MS ka\u017eejo ve\u010dje izbolj\u0161anje po zdravljenju z mati\u010dnimi celicami kot po klasi\u010dni terapiji.<\/p><\/blockquote>\n
– Harry Atkins, zdravnik, ki je vodil transplantacije mati\u010dnih celic, Bolni\u0161nica v Ottawi<\/cite><\/p>\n
Ni dvoma, da so rezultati te preliminarne \u0161tudije impresivni. Seveda ima \u0161tudija svoje omejitve, dokazi o uspe\u0161nosti so omejeni na bolnike, ki imajo nekonvencionalno ponavljajo\u010do se multiplo sklerozo. Potrebne bodo nadaljnje \u0161tudije in raziskave, da se potrdi splo\u0161na uporaba mati\u010dnih celice za zdravljenje multiple skleroze.<\/p>\n
Referenca:
\nhttps:\/\/jamanetwork.com\/<\/strong><\/a>
\nhttps:\/\/www.vox.com\/<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"V manj\u0161i klini\u010dni \u0161tudiji so potrdili, da se je ve\u010dini bolnikov z multiplo sklerozo (MS), ki so zraven kemoterapije prejeli tudi zdravljenje z mati\u010dnimi celicami, izbolj\u0161ala kvaliteta \u017eivljenja.<\/p>\n","protected":false},"author":25,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[218],"tags":[],"class_list":["post-9262","post","type-post","status-publish","format-standard","hentry","category-klinicne-posodobitve"],"acf":[],"yoast_head":"\n
Mati\u010dne celice izbolj\u0161ajo stanje pri bolnikih z multiplo sklerozo - nova \u0161tudija | Future Health Biobank<\/title>\n<meta name=\"description\" content=\"V manj\u0161i klini\u010dni \u0161tudiji so potrdili, da se je ve\u010dini bolnikov z multiplo sklerozo (MS), ki so zraven kemoterapije prejeli tudi zdravljenje z mati\u010dnimi celicami, izbolj\u0161ala kvaliteta \u017eivljenja.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"sl_SI\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mati\u010dne celice izbolj\u0161ajo stanje pri bolnikih z multiplo sklerozo - nova \u0161tudija | Future Health Biobank\" \/>\n<meta property=\"og:description\" content=\"V manj\u0161i klini\u010dni \u0161tudiji so potrdili, da se je ve\u010dini bolnikov z multiplo sklerozo (MS), ki so zraven kemoterapije prejeli tudi zdravljenje z mati\u010dnimi celicami, izbolj\u0161ala kvaliteta \u017eivljenja.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/\" \/>\n<meta property=\"og:site_name\" content=\"Future Health Biobank Slovenia\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-23T09:18:04+00:00\" \/>\n<meta name=\"author\" content=\"jwhybrow\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jwhybrow\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/\"},\"author\":{\"name\":\"jwhybrow\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\"},\"headline\":\"Mati\u010dne celice izbolj\u0161ajo stanje pri bolnikih z multiplo sklerozo – nova \u0161tudija\",\"datePublished\":\"2019-01-23T09:18:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/\"},\"wordCount\":455,\"commentCount\":0,\"articleSection\":[\"Klini\u010dne posodobitve\"],\"inLanguage\":\"sl-SI\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/\",\"url\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/\",\"name\":\"Mati\u010dne celice izbolj\u0161ajo stanje pri bolnikih z multiplo sklerozo - nova \u0161tudija | Future Health Biobank\",\"isPartOf\":{\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#website\"},\"datePublished\":\"2019-01-23T09:18:04+00:00\",\"author\":{\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\"},\"description\":\"V manj\u0161i klini\u010dni \u0161tudiji so potrdili, da se je ve\u010dini bolnikov z multiplo sklerozo (MS), ki so zraven kemoterapije prejeli tudi zdravljenje z mati\u010dnimi celicami, izbolj\u0161ala kvaliteta \u017eivljenja.\",\"inLanguage\":\"sl-SI\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#website\",\"url\":\"https:\/\/staging.futurehealthbiobank.com\/si\/\",\"name\":\"Future Health Biobank Slovenia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.futurehealthbiobank.com\/si\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sl-SI\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719\",\"name\":\"jwhybrow\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sl-SI\",\"@id\":\"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a281433b62a053423a023cad7e2a5257?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a281433b62a053423a023cad7e2a5257?s=96&d=mm&r=g\",\"caption\":\"jwhybrow\"},\"url\":\"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/author\/jwhybrow\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mati\u010dne celice izbolj\u0161ajo stanje pri bolnikih z multiplo sklerozo - nova \u0161tudija | Future Health Biobank","description":"V manj\u0161i klini\u010dni \u0161tudiji so potrdili, da se je ve\u010dini bolnikov z multiplo sklerozo (MS), ki so zraven kemoterapije prejeli tudi zdravljenje z mati\u010dnimi celicami, izbolj\u0161ala kvaliteta \u017eivljenja.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"sl_SI","og_type":"article","og_title":"Mati\u010dne celice izbolj\u0161ajo stanje pri bolnikih z multiplo sklerozo - nova \u0161tudija | Future Health Biobank","og_description":"V manj\u0161i klini\u010dni \u0161tudiji so potrdili, da se je ve\u010dini bolnikov z multiplo sklerozo (MS), ki so zraven kemoterapije prejeli tudi zdravljenje z mati\u010dnimi celicami, izbolj\u0161ala kvaliteta \u017eivljenja.","og_url":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/","og_site_name":"Future Health Biobank Slovenia","article_published_time":"2019-01-23T09:18:04+00:00","author":"jwhybrow","twitter_card":"summary_large_image","twitter_misc":{"Written by":"jwhybrow","Est. reading time":"2 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/#article","isPartOf":{"@id":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/"},"author":{"name":"jwhybrow","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719"},"headline":"Mati\u010dne celice izbolj\u0161ajo stanje pri bolnikih z multiplo sklerozo – nova \u0161tudija","datePublished":"2019-01-23T09:18:04+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/"},"wordCount":455,"commentCount":0,"articleSection":["Klini\u010dne posodobitve"],"inLanguage":"sl-SI","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/","url":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/","name":"Mati\u010dne celice izbolj\u0161ajo stanje pri bolnikih z multiplo sklerozo - nova \u0161tudija | Future Health Biobank","isPartOf":{"@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#website"},"datePublished":"2019-01-23T09:18:04+00:00","author":{"@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719"},"description":"V manj\u0161i klini\u010dni \u0161tudiji so potrdili, da se je ve\u010dini bolnikov z multiplo sklerozo (MS), ki so zraven kemoterapije prejeli tudi zdravljenje z mati\u010dnimi celicami, izbolj\u0161ala kvaliteta \u017eivljenja.","inLanguage":"sl-SI","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.futurehealthbiobank.com\/si\/blog\/maticne-celice-izboljsajo-stanje-pri-bolnikih-z-multiplo-sklerozo-nova-studija\/"]}]},{"@type":"WebSite","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#website","url":"https:\/\/staging.futurehealthbiobank.com\/si\/","name":"Future Health Biobank Slovenia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.futurehealthbiobank.com\/si\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sl-SI"},{"@type":"Person","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/7232eecb00f5f56f8f268c5ff3db6719","name":"jwhybrow","image":{"@type":"ImageObject","inLanguage":"sl-SI","@id":"https:\/\/staging.futurehealthbiobank.com\/si\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a281433b62a053423a023cad7e2a5257?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a281433b62a053423a023cad7e2a5257?s=96&d=mm&r=g","caption":"jwhybrow"},"url":"https:\/\/staging.futurehealthbiobank.com\/si\/blog\/author\/jwhybrow\/"}]}},"_links":{"self":[{"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/posts\/9262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/comments?post=9262"}],"version-history":[{"count":0,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/posts\/9262\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/media?parent=9262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/categories?post=9262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.futurehealthbiobank.com\/si\/wp-json\/wp\/v2\/tags?post=9262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}